United Biotech Private Limited — Ertapenem Exporter Profile
Indian Pharmaceutical Exporter · #8 for Ertapenem · $1.3M export value · DGFT Verified
United Biotech Private Limited is the #8 Indian exporter of Ertapenem with $1.3M in export value and 29 verified shipments. United Biotech Private Limited holds a 1.2% market share in Ertapenem exports across 9 countries. The company exports 30 pharmaceutical products worth $7.0M across 7 therapeutic categories.
United Biotech Private Limited — Ertapenem Export Profile: Buyers & Destinations
Where Does United Biotech Private Limited Export Ertapenem?
| Country | Value | Shipments | Share |
|---|---|---|---|
| PERU | $304.7K | 9 | 29.5% |
| CHILE | $243.9K | 5 | 23.6% |
| SRI LANKA | $226.9K | 5 | 21.9% |
| KAZAKHSTAN | $100.0K | 2 | 9.7% |
| GAUTEMALA | $74.0K | 2 | 7.2% |
| GUATEMALA | $44.9K | 1 | 4.3% |
| PARAGUAY | $25.5K | 3 | 2.5% |
| AUSTRIA | $13.1K | 1 | 1.3% |
| OMAN | $995 | 1 | 0.1% |
| COSTA RICA | $7 | 2 | 0.0% |
United Biotech Private Limited exports Ertapenem to 10 countries. The largest destination is PERU accounting for 29.5% of United Biotech Private Limited's Ertapenem shipments, followed by CHILE (23.6%) and SRI LANKA (21.9%). These destinations reflect United Biotech Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Ertapenem from United Biotech Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| LIBRA CHILE SA | CHILE | $243.9K | 5 |
| ADVANCE SCIENTIFIC DEL PERU S.A.C. | PERU | $188.3K | 4 |
| KAZBIOTECH LLP | KAZAKHSTAN | $100.0K | 2 |
| GEORGE STEUART HEALTH (PVT.)LTD | SRI LANKA | $96.0K | 2 |
| ADVANCE SCIENTIFIC DEL PERU S.A.C | PERU | $50.0K | 2 |
| NATIONAL DEVELOPMENT BANK PLC | SRI LANKA | $50.0K | 1 |
| TRADE SERVICES | SRI LANKA | $46.8K | 1 |
| PABLO CONTRERAS | GUATEMALA | $44.9K | 1 |
| PABLO CONTRERAS/SCHINDLER | GAUTEMALA | $43.7K | 1 |
| CORPORACION H&K PHARMA S.A.C | PERU | $40.0K | 2 |
United Biotech Private Limited supplies Ertapenem to 18 buyers globally. The largest buyer is LIBRA CHILE SA (CHILE), followed by ADVANCE SCIENTIFIC DEL PERU S.A.C. (PERU) and KAZBIOTECH LLP (KAZAKHSTAN). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Ertapenem Export Value and How Much Does United Biotech Private Limited Contribute?
India exported $35.1M worth of Ertapenem through 780 shipments from 54 suppliers to 46 countries, serving 137 buyers globally. United Biotech Private Limited contributes $1.3M to this total, accounting for 1.2% of India's Ertapenem exports. United Biotech Private Limited ships Ertapenem to 10 countries through 18 buyers.
What Is the Average Shipment Value for United Biotech Private Limited's Ertapenem Exports?
United Biotech Private Limited's average Ertapenem shipment value is $44.1K per consignment, based on 29 shipments totaling $1.3M. The largest destination is PERU (29.5% of United Biotech Private Limited's Ertapenem exports).
How Does United Biotech Private Limited Compare to Other Indian Ertapenem Exporters?
United Biotech Private Limited ranks #8 among 54 Indian Ertapenem exporters with a 1.2% market share. The top 3 exporters are EUGIA PHARMA SPECIALITIES LIMITED ($26.9M), DR.REDDY'S LABORATORIES LTD ($1.8M), GLAND PHARMA LIMITED ($1.4M). United Biotech Private Limited processed 29 shipments to 9 destination countries.
What Ertapenem Formulations Does United Biotech Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| LYORTAM 1 G (ERTAPENEM SODIUM FOR INJECT | $100.0K | 2 |
| PHARMA PRODUCT-LYORTAM 1 G(ERTAPENEM SOD | $96.0K | 2 |
| PHARMA PRODUCT-LYORTAM 1 G (ERTAPENEM SO | $93.9K | 2 |
| PHARMACEUTICAL MED PRODUCTS ERTAPAND Ertapenem For Injection 1g Batch No. EALA5B1 MFG 01/25 EXP 12/26 | $88.3K | 2 |
| ERTAPENEM FOR INJECTION VIAL 1G BATCH NO EALB5B4 MFG 02/2025 EXP 01/2027 | $50.0K | 2 |
| LYORTAM ERTAPENEM SODIUM FOR INJECTION | $50.0K | 1 |
| LYORTAM 1G ERTAPENEM SODIUM FOR INJECTION 1G B.NO. EALG3B11 M:7/23, E:6/25 | $50.0K | 1 |
| PHARMACEUTICAL MEDICINAL PRODUCTS ERTAPAND (ERTAPENEM FOR INJECTION 1G) BATCH EALK4B15 MFG:11/2024 EXP:10/2026 | $50.0K | 1 |
| PHARMACEUTICAL MEDICINAL PRODUCTS-ERTAPAND ERTAPENEM FOR INJECTION 1G,BT NO.EALB4B3,MFG-02/24,EXP-01/26 | $50.0K | 1 |
| PHARMACEUTICAL MEDICINAL PRODUCTS LYORTAM ERTAPENEM SODIUM FOR INJECTION 1.0 GMB:EALK4B13 M:11/24 EXP:10/26 | $50.0K | 1 |
United Biotech Private Limited exports 25 distinct Ertapenem formulations including tablets, capsules, syrups, and combination drugs. The top formulation is LYORTAM 1 G (ERTAPENEM SODIUM FOR INJECT with 2 shipments worth $100.0K.
How Does United Biotech Private Limited Compare to Nearest Ertapenem Exporters?
Exporters ranked immediately above and below #8 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 4 | DR.REDDY'S LABORATORIES LTD | $1.8M | 35 | 2 | $50.0K |
| 3 | GLAND PHARMA LIMITED | $1.4M | 29 | 4 | $50.0K |
| 8 | UNITED BIOTECH PRIVATE LIMITED ★ | $1.3M | 29 | 9 | $44.1K |
| 2 | JODAS EXPOIM PRIVATE LIMITED | $850.0K | 17 | 1 | $50.0K |
| 7 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $850.0K | 17 | 2 | $50.0K |
United Biotech Private Limited ranks #8 among 54 Indian Ertapenem exporters. Average shipment value of $44.1K compared to the market average of $649.6K. The closest competitors by value are DR.REDDY'S LABORATORIES LTD and GLAND PHARMA LIMITED.
Which Indian Ports Ship Ertapenem Exports?
| Port | Shipments | % Share |
|---|---|---|
| DELHI AIR CARGO ACC (INDEL4) | 248 | 31.8% |
| DELHI AIR | 185 | 23.7% |
| Delhi Air | 71 | 9.1% |
| HYDERABAD ACC (INHYD4) | 52 | 6.7% |
| HYDERABAD AIR | 33 | 4.2% |
| PETRAPOLE | 23 | 2.9% |
| SAHAR AIR | 21 | 2.7% |
| Dadri CGML | 19 | 2.4% |
What Other Advanced Antibiotics Products Does United Biotech Private Limited Export?
United Biotech Private Limited also exports these advanced antibiotics products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on United Biotech Private Limited's Ertapenem Exports
The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like United Biotech. The Israel-Iran conflict has escalated tensions in the Middle East, leading to disruptions in Red Sea shipping routes and increased freight costs. The Pharmaceuticals Export Promotion Council of India estimates potential losses between ₹2,500 crore and ₹5,000 crore due to these disruptions, affecting companies reliant on Middle Eastern markets. (telanganatoday.com)
Conversely, the U.S.-China trade tensions have opened avenues for Indian pharmaceutical firms to expand their footprint in the American market. However, recent U.S. tariff policies, including potential increases on pharmaceutical imports, pose a risk to this growth. President Trump's administration has threatened substantial tariff hikes to encourage domestic production, which could impact Indian exporters' competitiveness in the U.S. market. (lemonde.fr)
In the European Union, the implementation of the Falsified Medicines Directive (FMD) necessitates stringent compliance measures for exporters. Indian companies must adapt to these regulatory changes to maintain access to the EU market. The India–EFTA Trade and Economic Partnership Agreement, effective from October 2025, aims to reduce tariffs and promote trade, potentially benefiting exporters like United Biotech. (en.wikipedia.org)
United Biotech Private Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The U.S. FDA, WHO, and EU GMP guidelines set rigorous quality benchmarks that companies must meet to access global markets. While specific regulatory events concerning United Biotech are not detailed, adherence to these standards is essential for sustaining export operations.
The evolving quality requirements, including serialization and traceability mandates under the EU FMD, necessitate continuous investment in compliance infrastructure. Indian exporters must proactively adapt to these changes to ensure uninterrupted market access and maintain their reputation for quality.
About United Biotech Private Limited
United Biotech Private Limited exports 30 products worth $7.0M. Beyond Ertapenem, top products include Doxorubicin, Voriconazole, Cisplatin, Methylprednisolone, Docetaxel. View the complete United Biotech Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Ertapenem — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Ertapenem shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: United Biotech Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 31 individual customs records matching United Biotech Private Limited exporting Ertapenem, covering 25 formulations to 10 countries via 18 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 46+ countries, 137+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Ertapenem Export Data from United Biotech Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for United Biotech Private Limited's Ertapenem exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
United Biotech Private Limited
Full Company Profile →
30 products · $7.0M total trade · 7 categories
Ertapenem Stats
Company Overview
Top Products by United Biotech Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for United Biotech Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Ertapenem. For current shipment-level data, contact TransData Nexus.